On February 12, 2020, Armata Pharmaceuticals, Inc. announced Richard Bear and Michael S. Perry, D.V.M., Ph.D., resigned from the Board. Such resignations were not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Effective upon the resignations of Mr. Bear and Dr. Perry, two individuals designated by Innoviva, Sarah Schlesinger, M.D. and Odysseas Kostas, M.D., were appointed to fill the newly created vacancies.